top of page

Deep Brain Stimulation for Parkinson's Disease: The New Era of Adaptive Technology

A depiction on how Deep Brain Stimulation for Parkinson's Disease works.

Image is from Wikipedia CC


In a significant advancement for Parkinson's disease treatment, the FDA approved Medtronic's BrainSense Adaptive deep brain stimulation on February 24, 2025. This innovative implant represents the most personalized and responsive deep brain stimulator available, designed to respond dynamically to patients' changing brain signals throughout the day.


Unlike previous "always on" systems, this adaptive technology responds intelligently to brain signals, adjusting stimulation based on the patient's specific needs moment by moment. The result? Better symptom management and reduced medication dependency for patients struggling with this challenging neurological condition.


How Does Adaptive Deep Brain Stimulation Work?

The new adaptive deep brain stimulation (DBS) system fundamentally changes how we approach Parkinson's treatment. Dr. Helen Bronte-Stewart, professor of neurology at Stanford University, explains: "A deep brain stimulator is a brain pacemaker: similar to a cardiac pacemaker, except you insert electrodes in the brain to stimulate brain neurons."


What makes this technology revolutionary is its responsiveness. The system:

  1. Continuously monitors brain signals using BrainSenseâ„¢ technology

  2. Detects specific arrhythmias in beta patterns that fluctuate throughout the day

  3. Automatically adjusts stimulation levels to match the patient's changing symptoms

  4. Responds to medication timing, providing more stimulation when medicine wears off and less when it's active


"Like cardiac pacing, we've written an algorithm that responds to when patients take medication, and modulates the beta rhythm to the stable range and stops it from going too high or too low," explains Dr. Bronte-Stewart. "Brain pacemakers are finally catching up to cardiac pacemakers."


What Are the Benefits of Deep Brain Stimulation Surgery for Parkinson's Patients?

Clinical results demonstrate impressive outcomes for patients receiving this personalized approach to deep brain stimulation surgery:

  • Reduction in time experiencing worst symptoms from 25% to 12% of the day

  • Significant decrease in medication dependency (one patient reduced from 14-15 pills daily to just four)

  • Improved quality of life across mobility, pain, and daily activities

  • Better management of symptoms like dystonia, tremor, rigidity, and slowness


One patient, John Lipp, shared his experience: "I noticed a change almost immediately. My most problematic symptom was dystonia, or muscle cramping, which was both painful at times and debilitating. [After surgery] my dystonia pretty much went away. That, to me, is the most significant, life-changing benefit."


Are There Long-Term Effects of Deep Brain Stimulation Implants?

Current DBS technology provides long-term benefits while allowing flexibility for future treatments. The implant the DBS procedure involves positioning electrodes in the brain connected to a device implanted in the chest, similar to a pacemaker.


Modern devices can remain functional for approximately 15 years, with batteries replaceable through outpatient procedures. This provides sustainable symptom management while keeping options open for future treatments.


As John Lipp noted, "Let's say some miracle cure comes along; I can always have the device removed. That offers me a sense of security."


It's important to understand that while DBS significantly improves quality of life, it does not slow disease progression. Regular monitoring and occasional adjustment of the system are necessary as Parkinson's advances.


How Does AI Personalize Deep Brain Stimulation Treatment?

The adaptive approach leverages artificial intelligence to create individualized algorithms tailored to each patient's specific symptom patterns.


Dr. Philip Starr, professor of neurological surgery at UCSF, explains the challenge that motivated this innovation: "The brain changes in its needs moment to moment, hour to hour, week to week. So it's been a dream to make these stimulators self-regulating."


In a groundbreaking study published in Nature Medicine in August 2024, researchers demonstrated how AI-derived algorithms could read signals from two separate brain areas, delivering more stimulation during periods of stiffness and less during phases of involuntary movement.


Dr. Simon Little of UCSF provides a helpful metaphor: "When neurons start synchronizing together, when they start all firing at the same time, they're a bit like a crowd at a sports game. Some synchronization is good, but if you get over-synchronized, if your whole network starts chanting at the same time, then that's an unhealthy state because the brain is not really doing much information processing."


This technology represents a paradigm shift from conventional DBS, which delivers constant stimulation regardless of the patient's state.


Why Do Deep Brain Stimulation Effects Vary Among Patients?

Individual responses to DBS vary significantly based on factors including:

  • Specific symptoms (tremor, rigidity, dyskinesia)

  • Disease progression stage

  • Medication regimen

  • Individual brain signal patterns


The adaptive system addresses this variability by creating personalized algorithms. While initially time-consuming (the first patient's algorithm took two years to develop), the process has become more efficient, with the fourth patient's algorithm developed in just two weeks.

Dr. Jaimie Henderson, professor of neurosurgery at Stanford, sees this personalization as the future of treatment: "I do think this points the way that indeed personalized, individualized stimulation is the wave of the future."



What Other Innovations Are Advancing Deep Brain Stimulation?

The rapid evolution of DBS technology extends beyond Medtronic's adaptive system. According to Dr. Brett Youngerman from Columbia Neurosurgery, "New technologies are now making this treatment even more effective, customizable, and convenient for both patients and neurologists."


Recent innovations include:


Remote Programming Capabilities

Abbott has developed telehealth-based programming that allows neurologists to adjust DBS settings remotely. This eliminates frequent in-person visits—particularly beneficial for patients in remote areas or those with mobility challenges.


Enhanced Precision Stimulation

Boston Scientific's latest DBS device features more stimulation contacts than previous systems, enabling greater precision in targeting beneficial brain areas while avoiding structures that could cause side effects.


Practical Improvements

Across manufacturers, new implantable devices are now:

  • MRI-compatible, allowing patients to safely undergo magnetic resonance imaging

  • Equipped with rechargeable batteries, eliminating frequent replacement surgeries

  • Smaller and more comfortable than previous generations


What Should Patients Consider About Deep Brain Stimulation Surgery?

While adaptive DBS represents an exciting advancement, it's important to understand:

  1. DBS is typically considered when medications alone cannot adequately control symptoms

  2. The procedure involves brain surgery with associated risks

  3. Regular follow-up and adjustment are necessary, particularly as Parkinson's progresses

  4. Algorithms require frequent updates as symptoms and medications change

  5. Not all patients are ideal candidates—thorough evaluation is essential


Dr. Youngerman emphasizes the importance of a multidisciplinary approach: "We take pride in continuing to advance the field by offering the latest technology from each of the approved DBS manufacturers, ensuring that each patient receives a tailored therapy plan that aligns with their unique needs and priorities."


The Future of Adaptive Deep Brain Stimulation

The field continues to evolve rapidly. Dr. Henderson notes that testing these systems "in actual real-world conditions...is extremely impressive because that's a high bar. That's hard to do."


As algorithm development becomes more efficient and our understanding of brain signals advances, we can expect:

  • Faster personalization of treatment

  • Even more responsive systems

  • Integration with other therapies

  • Expanded applications beyond Parkinson's

  • Increased accessibility as technologies mature


For patients with Parkinson's disease, these advancements represent hope for better symptom management and improved quality of life through increasingly sophisticated, personalized interventions.


Neurology Associates: Expert Support for Parkinson's Patients

Neurology Associates Neuroscience Center at Chandler and Mesa locations offers comprehensive evaluation and management of Parkinson's disease, including assessment for deep brain stimulation therapy. Our team provides personalized care plans with flexible appointment options, including telemedicine consultations for qualifying patients. We collaborate with specialists to ensure patients have access to advanced treatment options like the innovative DBS systems described above.


IMPORTANT NOTE: This blog post is for informational purposes only and not medical advice. Always consult a qualified healthcare provider for diagnosis or treatment. Do not rely on this content as a substitute for professional medical guidance.


bottom of page